DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
ATIPAMEZOLE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ATIPAMEZOLE
×
Maximum Phase:
1
First Approval:
None
UNII:
03N9U5JAF6
Molecule Type:
Small molecule
Molecular Formula:
C14H16N2
Molecular Weight:
212.3
AlogP:
2.86
PSA:
28.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
LY3185643
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
LY3185643
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FF-10101
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Tyrosine-protein kinase receptor FLT3 inhibitor
FF-10101
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C29H38N8O2
Molecular Weight:
530.68
AlogP:
3.13
PSA:
126.28
HBD:
3.0
HBA:
#RotB:
13.0
Source:
MGS-0210
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MGS-0210
×
Maximum Phase:
1
First Approval:
None
UNII:
12XH8EKL2A
Molecule Type:
Small molecule
Molecular Formula:
C22H28Cl2FNO5
Molecular Weight:
476.37
AlogP:
4.53
PSA:
98.85
HBD:
2.0
HBA:
#RotB:
11.0
Source:
FACTOR IX COMPLEX
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
FACTOR IX COMPLEX
×
Maximum Phase:
1
First Approval:
None
UNII:
FW411QXD5M
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LODAPOLIMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Melanoma; Neoplasms; Pancreatic Neoplasms
Unknown
LODAPOLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
NR4MAD6PPB
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELUFORSEN
1
Oligonucleotide
Investigational
Unknown
Unknown
Cystic Fibrosis
Unknown
ELUFORSEN
×
Maximum Phase:
1
First Approval:
None
UNII:
V30WFP6S2Y
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CANOCTAKIN
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
CANOCTAKIN
×
Maximum Phase:
1
First Approval:
None
UNII:
MU4128F2CO
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REBAUDIOSIDE A
1
Oligosaccharide
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
REBAUDIOSIDE A
×
Maximum Phase:
1
First Approval:
None
UNII:
B3FUD0528F
Molecule Type:
Oligosaccharide
Molecular Formula:
C44H70O23
Molecular Weight:
967.02
AlogP:
-5.11
PSA:
374.13
HBD:
14.0
HBA:
#RotB:
12.0
Source:
PSI-697
1
Small molecule
Investigational
Unknown
Unknown
Scleritis
Unknown
PSI-697
×
Maximum Phase:
1
First Approval:
None
UNII:
LH1XC916ME
Molecule Type:
Small molecule
Molecular Formula:
C21H18ClNO3
Molecular Weight:
367.83
AlogP:
4.76
PSA:
70.42
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TIGAPOTIDE TRIFLUTATE
1
Protein
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
TIGAPOTIDE TRIFLUTATE
×
Maximum Phase:
1
First Approval:
None
UNII:
6227JFW01C
Molecule Type:
Protein
Molecular Formula:
C84H120F3N21O36S3
Molecular Weight:
2153.19
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
GSK-1614235
1
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
GSK-1614235
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TALINOLOL
1
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Obesity, Morbid
Unknown
TALINOLOL
×
Maximum Phase:
1
First Approval:
None
UNII:
3S82268BKG
Molecule Type:
Small molecule
Molecular Formula:
C20H33N3O3
Molecular Weight:
363.5
AlogP:
3.27
PSA:
82.62
HBD:
4.0
HBA:
#RotB:
7.0
Source:
LIATERMIN
1
Protein
Investigational
Unknown
Unknown
Parkinson Disease
GDNF family receptor alpha-1 agonist
LIATERMIN
×
Maximum Phase:
1
First Approval:
None
UNII:
PI2EOQ4KE3
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MCAF5352A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MCAF5352A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MITOQUINOL CATION
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MITOQUINOL CATION
×
Maximum Phase:
1
First Approval:
None
UNII:
65M41NIO61
Molecule Type:
Small molecule
Molecular Formula:
C37H46O4P+
Molecular Weight:
585.75
AlogP:
8.08
PSA:
58.92
HBD:
2.0
HBA:
#RotB:
16.0
Source:
TRX-518
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Melanoma; Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms, Castration-Resistant
Tumor necrosis factor receptor superfamily member 18 agonist
TRX-518
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELTANEXOR
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ELTANEXOR
×
Maximum Phase:
1
First Approval:
None
UNII:
Q59IQJ9NTK
Molecule Type:
Small molecule
Molecular Formula:
C17H10F6N6O
Molecular Weight:
428.3
AlogP:
3.26
PSA:
99.58
HBD:
1.0
HBA:
#RotB:
4.0
Source:
NT-219
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NT-219
×
Maximum Phase:
1
First Approval:
None
UNII:
K1WT1A1UP5
Molecule Type:
Small molecule
Molecular Formula:
C16H14BrNO5S
Molecular Weight:
412.26
AlogP:
3.11
PSA:
113.18
HBD:
6.0
HBA:
#RotB:
4.0
Source:
AVOPLACEL
1
Cell
Investigational
Unknown
Unknown
Unknown
Unknown
AVOPLACEL
×
Maximum Phase:
1
First Approval:
None
UNII:
79NT7I8J0C
Molecule Type:
Cell
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METHANESULFONYL FLUORIDE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
METHANESULFONYL FLUORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
9H250YYY0R
Molecule Type:
Small molecule
Molecular Formula:
CH3FO2S
Molecular Weight:
98.1
AlogP:
-0.08
PSA:
34.14
HBD:
0.0
HBA:
#RotB:
0.0
Source:
ILORASERTIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Platelet-derived growth factor receptor inhibitor
ILORASERTIB
×
Maximum Phase:
1
First Approval:
None
UNII:
6L5D03D975
Molecule Type:
Small molecule
Molecular Formula:
C25H21FN6O2S
Molecular Weight:
488.55
AlogP:
5.18
PSA:
118.09
HBD:
4.0
HBA:
#RotB:
6.0
Source:
PLX-7486
1
Small molecule
Investigational
Unknown
Unknown
Giant Cell Tumors
Macrophage colony stimulating factor receptor inhibitor
PLX-7486
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RALPANCIZUMAB
1
Antibody
Investigational
Unknown
Unknown
Hypercholesterolemia
Subtilisin/kexin type 9 inhibitor
RALPANCIZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
YB9L51E4MD
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SAMROTAMAB VEDOTIN
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Squamous Cell; Histiocytoma, Malignant Fibrous
Unknown
SAMROTAMAB VEDOTIN
×
Maximum Phase:
1
First Approval:
None
UNII:
SY5HF6N5MB
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TUROFEXORATE ISOPROPYL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Bile acid receptor FXR agonist
TUROFEXORATE ISOPROPYL
×
Maximum Phase:
1
First Approval:
None
UNII:
S6KDM312I5
Molecule Type:
Small molecule
Molecular Formula:
C25H24F2N2O3
Molecular Weight:
438.47
AlogP:
5.17
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
3.0
Source:
MDX-1342
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell
B-lymphocyte antigen CD19 binding agent
MDX-1342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COCAETHYLENE
1
Small molecule
Investigational
Unknown
Unknown
Cocaine-Related Disorders
Unknown
COCAETHYLENE
×
Maximum Phase:
1
First Approval:
None
UNII:
FJO3071W5Y
Molecule Type:
Small molecule
Molecular Formula:
C18H23NO4
Molecular Weight:
317.39
AlogP:
2.26
PSA:
55.84
HBD:
0.0
HBA:
#RotB:
4.0
Source:
BALAFILCON A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BALAFILCON A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UNESBULIN
1
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Leiomyosarcoma; Neoplasms; Ovarian Neoplasms
Unknown
UNESBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4HZ70S62Q
Molecule Type:
Small molecule
Molecular Formula:
C19H13F5N6
Molecular Weight:
420.35
AlogP:
4.75
PSA:
81.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
APVO-414
1
Unknown
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
APVO-414
×
Maximum Phase:
1
First Approval:
None
UNII:
56JX9SY1PG
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SELITRECTINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Neurotrophic tyrosine kinase receptor inhibitor
SELITRECTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
0J45910S3X
Molecule Type:
Small molecule
Molecular Formula:
C20H21FN6O
Molecular Weight:
380.43
AlogP:
2.67
PSA:
75.42
HBD:
1.0
HBA:
#RotB:
0.0
Source:
AMG553
1
Cell
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Tyrosine-protein kinase receptor FLT3 binding agent
AMG553
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Cell
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RINTODESTRANT
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Ductal
Unknown
RINTODESTRANT
×
Maximum Phase:
1
First Approval:
None
UNII:
W3Y784Y0ES
Molecule Type:
Small molecule
Molecular Formula:
C26H19FO5S
Molecular Weight:
462.5
AlogP:
6.48
PSA:
83.83
HBD:
2.0
HBA:
#RotB:
6.0
Source:
HYDROXYNORKETAMINE, (2R,6R)
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HYDROXYNORKETAMINE, (2R,6R)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H14ClNO2
Molecular Weight:
239.7
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
1
2
…
96
97
98
99
100
101
102
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA